Abstract
Allosteric enhancers at the adenosine A1 receptor have received attention as anti-arrhythmic cardiac agents, and, more recently, as anti-lipolytic agents. In addition, allosteric modulators at the adenosine A1 receptor have therapeutic potential as analgesics and neuroprotective agents. In particular, the compounds with improved potency as enhancers and reduced antagonist properties are mentioned.
Keywords: A1-adenosine receptor, allosteric modulators, enhancer, cAMP content, neuroprotection
Mini-Reviews in Medicinal Chemistry
Title: Allosteric Enhancers for A1 Adenosine Receptor
Volume: 7 Issue: 6
Author(s): Pier Giovanni Baraldi, Maria Antonietta Iaconinoto, Allan R. Moorman, Maria Dora Carrion, Carlota Lopez Cara, Delia Preti, Olga Cruz Lopez, Francesca Fruttarolo, Mojgan Aghazadeh Tabrizi and Romeo Romagnoli
Affiliation:
Keywords: A1-adenosine receptor, allosteric modulators, enhancer, cAMP content, neuroprotection
Abstract: Allosteric enhancers at the adenosine A1 receptor have received attention as anti-arrhythmic cardiac agents, and, more recently, as anti-lipolytic agents. In addition, allosteric modulators at the adenosine A1 receptor have therapeutic potential as analgesics and neuroprotective agents. In particular, the compounds with improved potency as enhancers and reduced antagonist properties are mentioned.
Export Options
About this article
Cite this article as:
Pier Giovanni Baraldi , Maria Antonietta Iaconinoto , Allan R. Moorman , Maria Dora Carrion , Carlota Lopez Cara , Delia Preti , Olga Cruz Lopez , Francesca Fruttarolo , Mojgan Aghazadeh Tabrizi and Romeo Romagnoli , Allosteric Enhancers for A1 Adenosine Receptor, Mini-Reviews in Medicinal Chemistry 2007; 7 (6) . https://dx.doi.org/10.2174/138955707780859459
DOI https://dx.doi.org/10.2174/138955707780859459 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Goto-kakizaki Rats: Its Suitability as Non-obese Diabetic Animal Model for Spontaneous Type 2 Diabetes Mellitus
Current Diabetes Reviews Management of Hypertension in Relation to Acute Coronary Syndromes and Revascularisation
Current Pharmaceutical Design Neuroprotection by the α2-Adrenoceptor Agonist, Dexmedetomidine, in Experimental Stroke Models
Vascular Disease Prevention (Discontinued) Interactions Between Plasma Proteins and Naturally Occurring Polyphenols
Current Drug Metabolism Macrophage-Derived Foam Cells in Atherosclerosis: Lessons from Murine Models and Implications for Therapy
Current Drug Targets Monitoring Therapeutic Anticoagulation with Low Molecular Weight Heparins: Is it Useful or Misleading?
Cardiovascular & Hematological Agents in Medicinal Chemistry The Effects of Obesity on the Cerebral Vasculature
Current Vascular Pharmacology A Hopeful Prospect of Riociguat as a Soluble Guanylate Cyclase Stimulator for Management of Pressure Ulcers
Current Drug Discovery Technologies Medical Treatment of Aortic Aneurysms in Marfan Syndrome and other Heritable Conditions
Current Cardiology Reviews The Prothrombotic State in Hypertension and the Effects of Antihypertensive Treatment
Current Pharmaceutical Design Cystatin C in Cerebrovascular Disorders
Current Neurovascular Research Osteoprotegerin in Cardiovascular Disease: Ally or Enemy?
Current Pharmaceutical Design Oxidative Stress and Vascular Disease
Current Hypertension Reviews Low Activity of Plasminogen Activator: A Common Feature of Non- Iatrogenic Comorbidities of Schizophrenia
CNS & Neurological Disorders - Drug Targets PPARγ Agonists: Beneficial Effect on Blood Pressure Beyond Glycemic Control?
Current Hypertension Reviews Therapeutic Interventions to Renin-Angiotensin-Aldosterone System, and Vascular Redox State
Recent Patents on Cardiovascular Drug Discovery The Peri-Viable Baby Down Under - An Australian Perspective on the "Grey Zone" of Viability
Current Pediatric Reviews Understanding eNOS for Pharmacological Modulation of Endothelial Function: A Translational View
Current Pharmaceutical Design Virus-Associated Vasculitides: An Update
Current Immunology Reviews (Discontinued) Biochemical, Hematological and Histopathological Indices of Wistar Rats Fed Vitamin and Mineral Deficient Diets Supplemented with Moringa oleifera Leaf Meal
Current Nutrition & Food Science